In line with this hypothesis, it has been shown that increased aldehyde levels due to mutations in both ALDH2 and ADH5 result in aplastic anaemia, mental retardation and dwarfism (AMed) syndrome that is characterized by neuronal clinical features that overlap with CS52,72. This evidence concerns the gene ADH5 and aplastic anemia.